US Patent Issued to OXFORD UNIVERSITY INNOVATION on Oct. 27 for "Biomarkers for the prediction and identification of Parkinson's disease" (British Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,775,008, issued on Oct. 27, was assigned to OXFORD UNIVERSITY INNOVATION Ltd. (Oxford, Great Britain).

"Biomarkers for the prediction and identification of Parkinson's disease" was invented by George Tofaris (Oxford, Great Britain), Jason Davis (Oxford, Great Britain) and Cheng Jiang (Oxford, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to using serum exosomal proteins, Alpha-synuclein and clusterin, as biomarkers in the prediction and identification of a subject having Parkinson's Disease, and provides methods for determining their levels. The biomarkers are also useful for monitoring, prevention and/or treatment o...